Search research articles
Contact Us
Filters
Showing results (71-80 of 119) with videos related to
Page
of 12
Sort By:
American Journal of Hematology
|
January 22, 2019
Eligibility for CAR T-cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCL
Stephen D Smith, Prathima Reddy, Alexandra Sokolova, et al.
Cancer Immunology Research
|
May 20, 2016
Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab
Gregory A Rufener, Oliver W Press, Philip Olsen, et al.
Blood Advances
|
June 17, 2025
Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomas
Christina Poh, Jenna M Voutsinas, Mazyar Shadman, et al.
Cancer Research
|
June 2, 2017
Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas
Shyril O'Steen, Damian J Green, Ajay K Gopal, et al.
British Journal of Haematology
|
February 8, 2020
Pembrolizumab with R-CHOP in previously untreated diffuse large B-cell lymphoma: potential for biomarker driven therapy
Stephen D Smith, Brian G Till, Mazyar S Shadman, et al.
Journal of Cellular and Molecular Medicine
|
December 1, 2022
Predictors of response to axicabtagene-ciloleucel CAR T cells in aggressive B cell lymphomas: A real-world study
Lorenzo Iovino, Qian Vicky Wu, Jenna Voutsinas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2011
Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation
Lihua E Budde, Katherine A Guthrie, Brian G Till, et al.
Frontiers in Immunology
|
August 1, 2022
Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies
Hao Huang, Ling Peng, Bicheng Zhang, et al.
Leukemia & Lymphoma
|
July 11, 2022
Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphoma
Lorena Panaite, Qian Vicky Wu, Jenna Voutsinas, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 5, 2023
Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up
Carrie Ho, Ajay K Gopal, Brian G Till, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 119) with videos related to
Sort By:
Page
of 12
American Journal of Hematology
|
January 22, 2019
Eligibility for CAR T-cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCL
Stephen D Smith, Prathima Reddy, Alexandra Sokolova, et al.
Cancer Immunology Research
|
May 20, 2016
Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab
Gregory A Rufener, Oliver W Press, Philip Olsen, et al.
Blood Advances
|
June 17, 2025
Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomas
Christina Poh, Jenna M Voutsinas, Mazyar Shadman, et al.
Cancer Research
|
June 2, 2017
Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas
Shyril O'Steen, Damian J Green, Ajay K Gopal, et al.
British Journal of Haematology
|
February 8, 2020
Pembrolizumab with R-CHOP in previously untreated diffuse large B-cell lymphoma: potential for biomarker driven therapy
Stephen D Smith, Brian G Till, Mazyar S Shadman, et al.
Journal of Cellular and Molecular Medicine
|
December 1, 2022
Predictors of response to axicabtagene-ciloleucel CAR T cells in aggressive B cell lymphomas: A real-world study
Lorenzo Iovino, Qian Vicky Wu, Jenna Voutsinas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2011
Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation
Lihua E Budde, Katherine A Guthrie, Brian G Till, et al.
Frontiers in Immunology
|
August 1, 2022
Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies
Hao Huang, Ling Peng, Bicheng Zhang, et al.
Leukemia & Lymphoma
|
July 11, 2022
Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphoma
Lorena Panaite, Qian Vicky Wu, Jenna Voutsinas, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 5, 2023
Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up
Carrie Ho, Ajay K Gopal, Brian G Till, et al.
Page
of 12